Samsung Medical Center is a large tertiary and quaternary care hospital located in Seoul, operated by the Samsung Medical Center Foundation, a non-profit organisation that is a subsidiary of Samsung Group. Established in 1994 with 1,979 beds and approximately 2,000 staff, the hospital operates at a scale that supports comprehensive sub-specialty care across cardiology, oncology, orthopaedics, neurology, and numerous other disciplines. It holds both JCI accreditation and accreditation from KOIHA, the Korean Institute for Healthcare Accreditation.
The hospital's cardiac surgery and orthopaedic departments are its most prominent services for international patients, with coronary artery bypass grafting and knee replacement among the most frequently performed procedures. The hospital is consistently ranked among the large-volume tertiary hospitals in Asia for clinical outcomes, and its research output is extensive given its affiliation with Sungkyunkwan University School of Medicine.
International patient services are managed through a dedicated international health services centre that provides interpretation in Korean, English, Chinese, Arabic, and other languages. The centre handles pre-admission coordination, visa documentation support, airport transfers, and accommodation guidance. Pricing is not published publicly; individual cost estimates are provided through the international department following diagnostic review.
Surgical and diagnostic infrastructure includes cardiac catheterisation laboratories, robotic surgical systems, PET-CT and MRI imaging suites, and a clinical laboratory operating under KOIHA and JCI standards. The hospital's scale and institutional governance structure provide a high level of clinical oversight and quality assurance.